Home > PE Ratio > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 56.84.

Share Price ₹2,265.1Dec 24,2024
Market Cap ₹38,370.8 Cr
Earnings-TTM₹675.0 CrTTM-Consolidated Results
Price/Earnings56.84xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of GLAXOSMITHKLINE PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of GLAXOSMITHKLINE PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹38,370.8 Cr] as on Dec 24,2024

(/) Earnings [ ₹675.0 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 56.84x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for GLAXOSMITHKLINE PHARMACEUTICALS , the investors are currently willing to pay 56.84 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GLAXOSMITHKLINE PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of GLAXOSMITHKLINE PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of GLAXOSMITHKLINE PHARMACEUTICALS


PE Ratio Performance Analysis for GLAXOSMITHKLINE PHARMACEUTICALS

- GLAXOSMITHKLINE PHARMACEUTICALS 's latest p/e ratio is 56.84x.

- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 80.72x.

- GLAXOSMITHKLINE PHARMACEUTICALS 's operated at median p/e ratio of 55.8x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio peaked in Mar2020 at 226.34x.

- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2022 of 16.62x.


How does GLAXOSMITHKLINE PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
GLAXOSMITHKLINE PHARMACEUTICALS 675.0356.8438,370.8
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5039.16436,103.0
CIPLA LTD4,485.2226.58119,196.0
DR REDDYS LABORATORIES LTD5,406.8020.85112,752.0
ZYDUS LIFESCIENCES LTD4,298.9022.5797,041.2
DIVIS LABORATORIES LTD1,836.0083.63153,540.0
MANKIND PHARMA LTD2,124.8656.51120,073.0
TORRENT PHARMACEUTICALS LTD1,802.0063.88115,112.0
LUPIN LTD2,651.9437.3098,925.3
AUROBINDO PHARMA LTD3,598.8320.3773,314.6
ABBOTT INDIA LTD1,284.6647.0860,480.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GLAXOSMITHKLINE PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 20.37x
Max industry PE 83.63x
Median industry PE 39.16x
Average industry PE 43.16x



You may also like the below Video Courses